Hypoparathyroidism Treatment Market

Hypoparathyroidism treatment sales will expand through 2035, with calcium supplements at 37.9% of the drug category and retail pharmacies at 37.1% of distribution channel demand in 2025. The market was valued at USD 785.7 million in 2025 and is forecast to record a 3.9% CAGR between 2025 and 2035.